157 related articles for article (PubMed ID: 11817766)
1. Cocaine withdrawal severity and urine toxicology results from treatment entry predict outcome in medication trials for cocaine dependence.
Kampman KM; Volpicelli JR; Mulvaney F; Rukstalis M; Alterman AI; Pettinati H; Weinrieb RM; O'Brien CP
Addict Behav; 2002; 27(2):251-60. PubMed ID: 11817766
[TBL] [Abstract][Full Text] [Related]
2. Cocaine withdrawal symptoms and initial urine toxicology results predict treatment attrition in outpatient cocaine dependence treatment.
Kampman KM; Alterman AI; Volpicelli JR; Maany I; Muller ES; Luce DD; Mulholland EM; Jawad AF; Parikh GA; Mulvaney FD; Weinrieb RM; O'Brien CP
Psychol Addict Behav; 2001 Mar; 15(1):52-9. PubMed ID: 11255939
[TBL] [Abstract][Full Text] [Related]
3. Predictors of treatment outcome in outpatient cocaine and alcohol dependence treatment.
Ahmadi J; Kampman KM; Oslin DM; Pettinati HM; Dackis C; Sparkman T
Am J Addict; 2009; 18(1):81-6. PubMed ID: 19219669
[TBL] [Abstract][Full Text] [Related]
4. Outcome predictors in cocaine dependence treatment trials.
Ahmadi J; Kampman K; Dackis C
Am J Addict; 2006; 15(6):434-9. PubMed ID: 17182445
[TBL] [Abstract][Full Text] [Related]
5. Cocaine abstinence symptomatology and treatment attrition.
Mulvaney FD; Alterman AI; Boardman CR; Kampman K
J Subst Abuse Treat; 1999 Mar; 16(2):129-35. PubMed ID: 10023610
[TBL] [Abstract][Full Text] [Related]
6. The combination of phentermine and fenfluramine reduced cocaine withdrawal symptoms in an open trial.
Kampman KM; Rukstalis M; Pettinati H; Muller E; Acosta T; Gariti P; Ehrman R; O'Brien CP
J Subst Abuse Treat; 2000 Jul; 19(1):77-9. PubMed ID: 10867304
[No Abstract] [Full Text] [Related]
7. Cocaine withdrawal symptoms identify "Type B" cocaine-dependent patients.
Ahmadi J; Kampman K; Dackis C; Sparkman T; Pettinati H
Am J Addict; 2008; 17(1):60-4. PubMed ID: 18214724
[TBL] [Abstract][Full Text] [Related]
8. Sertraline delays relapse in recently abstinent cocaine-dependent patients with depressive symptoms.
Oliveto A; Poling J; Mancino MJ; Williams DK; Thostenson J; Pruzinsky R; Gonsai K; Sofuoglu M; Gonzalez G; Tripathi S; Kosten TR
Addiction; 2012 Jan; 107(1):131-41. PubMed ID: 21707811
[TBL] [Abstract][Full Text] [Related]
9. Reliability and validity of the Cocaine Selective Severity Assessment.
Kampman KM; Volpicelli JR; McGinnis DE; Alterman AI; Weinrieb RM; D'Angelo L; Epperson LE
Addict Behav; 1998; 23(4):449-61. PubMed ID: 9698974
[TBL] [Abstract][Full Text] [Related]
10. A double-blind, placebo-controlled trial of amantadine, propranolol, and their combination for the treatment of cocaine dependence in patients with severe cocaine withdrawal symptoms.
Kampman KM; Dackis C; Lynch KG; Pettinati H; Tirado C; Gariti P; Sparkman T; Atzram M; O'Brien CP
Drug Alcohol Depend; 2006 Nov; 85(2):129-37. PubMed ID: 16697124
[TBL] [Abstract][Full Text] [Related]
11. Correlates of polysomnographic sleep changes in cocaine dependence: self-administration and clinical outcomes.
Angarita GA; Canavan SV; Forselius E; Bessette A; Morgan PT
Drug Alcohol Depend; 2014 Oct; 143():173-80. PubMed ID: 25124303
[TBL] [Abstract][Full Text] [Related]
12. Baseline prediction of 7-month cocaine abstinence for cocaine dependence patients.
Alterman AI; McKay JR; Mulvaney FD; Cnaan A; Cacciola JS; Tourian KA; Rutherford MJ; Merikle EP
Drug Alcohol Depend; 2000 Jun; 59(3):215-21. PubMed ID: 10812282
[TBL] [Abstract][Full Text] [Related]
13. DHEAS and POMS measures identify cocaine dependence treatment outcome.
Wilkins JN; Majewska MD; Van Gorp W; Li SH; Hinken C; Plotkin D; Setoda D
Psychoneuroendocrinology; 2005 Jan; 30(1):18-28. PubMed ID: 15358439
[TBL] [Abstract][Full Text] [Related]
14. Amantadine in the treatment of cocaine-dependent patients with severe withdrawal symptoms.
Kampman KM; Volpicelli JR; Alterman AI; Cornish J; O'Brien CP
Am J Psychiatry; 2000 Dec; 157(12):2052-4. PubMed ID: 11097979
[TBL] [Abstract][Full Text] [Related]
15. Dextroamphetamine for cocaine-dependence treatment: a double-blind randomized clinical trial.
Grabowski J; Rhoades H; Schmitz J; Stotts A; Daruzska LA; Creson D; Moeller FG
J Clin Psychopharmacol; 2001 Oct; 21(5):522-6. PubMed ID: 11593078
[TBL] [Abstract][Full Text] [Related]
16. Extended-Release Mixed Amphetamine Salts vs Placebo for Comorbid Adult Attention-Deficit/Hyperactivity Disorder and Cocaine Use Disorder: A Randomized Clinical Trial.
Levin FR; Mariani JJ; Specker S; Mooney M; Mahony A; Brooks DJ; Babb D; Bai Y; Eberly LE; Nunes EV; Grabowski J
JAMA Psychiatry; 2015 Jun; 72(6):593-602. PubMed ID: 25887096
[TBL] [Abstract][Full Text] [Related]
17. A double-blind, placebo-controlled trial of modafinil for cocaine dependence.
Dackis CA; Kampman KM; Lynch KG; Pettinati HM; O'Brien CP
Neuropsychopharmacology; 2005 Jan; 30(1):205-11. PubMed ID: 15525998
[TBL] [Abstract][Full Text] [Related]
18. Clinical efficacy of sertraline alone and augmented with gabapentin in recently abstinent cocaine-dependent patients with depressive symptoms.
Mancino MJ; McGaugh J; Chopra MP; Guise JB; Cargile C; Williams DK; Thostenson J; Kosten TR; Sanders N; Oliveto A
J Clin Psychopharmacol; 2014 Apr; 34(2):234-9. PubMed ID: 24525654
[TBL] [Abstract][Full Text] [Related]
19. How treatment improvement in ADHD and cocaine dependence are related to one another: A secondary analysis.
Levin FR; Choi CJ; Pavlicova M; Mariani JJ; Mahony A; Brooks DJ; Nunes EV; Grabowski J
Drug Alcohol Depend; 2018 Jul; 188():135-140. PubMed ID: 29775957
[TBL] [Abstract][Full Text] [Related]
20. Pemoline for the treatment of cocaine dependence in methadone-maintained patients.
Margolin A; Avants SK; Kosten TR
J Psychoactive Drugs; 1996; 28(3):301-4. PubMed ID: 8895115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
